Scarica l'app Stockscreener
3.441
0.03%
0.0010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.44
Aprire:
$3.44
Volume 24 ore:
20,994
Relative Volume:
0.43
Capitalizzazione di mercato:
$51.48M
Reddito:
$37.79M
Utile/perdita netta:
$-10.38M
Rapporto P/E:
-4.7137
EPS:
-0.73
Flusso di cassa netto:
$-1.00M
1 W Prestazione:
-3.13%
1M Prestazione:
+2.41%
6M Prestazione:
-24.04%
1 anno Prestazione:
+173.10%
Intervallo 1D:
$3.40
$3.52
Intervallo di 1 settimana:
$3.29
$3.6884
Portata 52W:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
2525 WEST END AVENUE, NASHVILLE,, TN
Confronta CPIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.441 | 50.56M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
143.79 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.205 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.77 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.10 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2012-11-12 | Reiterato | UBS | Neutral |
| 2011-02-01 | Reiterato | UBS | Neutral |
| 2010-12-16 | Downgrade | UBS | Buy → Neutral |
| 2010-08-17 | Downgrade | Jefferies | Buy → Hold |
| 2010-08-17 | Reiterato | Morgan Joseph | Buy |
| 2010-08-17 | Reiterato | UBS | Buy |
| 2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidanceJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
Is Cumberland Pharmaceuticals Inc. a candidate for recovery playShort Setup & Long Hold Capital Preservation Plans - newser.com
Cumberland Pharmaceuticals Inc Stock Analysis and ForecastHealthcare Stock Analysis & Real-Life Case Studies You Can Follow - earlytimes.in
Analyzing net buyer seller activity in Cumberland Pharmaceuticals Inc.Trade Volume Summary & Short-Term High Return Ideas - newser.com
How to build a dashboard for Cumberland Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. - Stock Titan
Can volume confirm reversal in Cumberland Pharmaceuticals Inc.Chart Signals & Precise Entry and Exit Recommendations - newser.com
What the charts say about Cumberland Pharmaceuticals Inc. today2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. still worth holding after the dipMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com
Why Cumberland Pharmaceuticals Inc. stock is recommended by analystsEarnings Miss & Smart Allocation Stock Reports - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Cumberland Pharmaceuticals (NASDAQ:CPIX) - MarketBeat
How to manage a losing position in Cumberland Pharmaceuticals Inc.Trade Volume Report & Low Risk Profit Maximizing Plans - newser.com
Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S No Reason For Excitement - simplywall.st
Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight - GlobeNewswire Inc.
Published on: 2025-10-06 05:25:30 - newser.com
Will Cumberland Pharmaceuticals Inc. benefit from macro trendsTrend Reversal & Accurate Entry/Exit Alerts - newser.com
Published on: 2025-10-06 02:33:45 - newser.com
Should you wait for a breakout in Cumberland Pharmaceuticals Inc.Earnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Sentiment analysis tools applied to Cumberland Pharmaceuticals Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Tick level data insight on Cumberland Pharmaceuticals Inc. volatilityWatch List & High Accuracy Swing Entry Alerts - newser.com
Cumberland Pharmaceuticals Announces Product Approval in Mexico - MarketScreener
Cumberland’s injectable ibuprofen receives approval in Mexico By Investing.com - Investing.com South Africa
Cumberland’s injectable ibuprofen receives approval in Mexico - Investing.com India
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO - WV News
Revolutionary Drug-Resistant Bacteria Fighter: Tabuk Brings Vibativ Antibiotic to Saudi Healthcare System - Stock Titan
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA - Sahm
Is Cumberland Pharmaceuticals Inc a good long term investmentEarnings Per Share Trends & Free Long-Term Investment Planning - earlytimes.in
What analysts say about Cumberland Pharmaceuticals Inc stockTechnical Analysis Insights & Reinvest for Maximum Compounding Returns - earlytimes.in
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):